Ranitidine Market Take Advantage and Grow – Read These Few Tips
The Ranitidine Market analysis report speaks about the growth rate till 2027 manufacturing process, Growth, key factors driving this market with sales, revenue, and price analysis of lead manufacturers, distributors, traders and dealers of Ranitidine.
Coherent Market Insights always aims at offering their clients an in-depth analysis and the best research of the various market. The “Ranitidine Market projected to develop with growing expansion prospects”. The Ranitidine Market report presents a calculated opinion of the analyzed Ranitidine Market data. It explains various opportunities dedicated to different industries, suppliers, organizations, and associations offering various products and services such as offering them precise guidance for their expansion in the competition for reliable services to consumers. The report provides detailed information on key competitors in the market and on emerging companies with significant market share based on demand, revenue, sales, high-quality product manufacturers, and service providers.
Overview
Due to the rising incidence of gastroesophageal reflux disease (GERD) and stomach and intestinal ulcers, healthcare experts have taken a particular interest in their treatment. GERD is a frequent health condition that can result in major medical problems as well as a significant financial outlay for diagnosis and treatment. Heartburn and acid regurgitation are the two most common symptoms linked with GERD. To lessen the incidence of stomach acids or prevent acid production, over-the-counter antacids, proton pump inhibitors, and H-2 receptor blockers are often utilized.
Ranitidine is a histamine H2 antagonist that is used to treat gastroesophageal reflux disease. It is available as an over-the-counter (OTC) and prescription medication (GERD). For up to 12 hours, ranitidine reduces stomach acid production. Erosive esophagitis, peptide ulcer disease, and Zollinger–Ellison syndrome are all treated with ranitidine. It can be consumed orally or intravenously.
The global ranitidine market was worth US$ 412.4 million in 2018, and it is anticipated to grow at a CAGR of 1.8 percent from 2019 to 2027.
The prominent players in the Ranitidine Market are GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Strides Pharma Science Limited (StridesShasun), Tocris Bioscience (R & D Systems), Merck KGaA, and Sun Pharmaceutical Industries Limited among others.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/2131
Drivers
Increasing Ranitidine Research and Development (R&D) is projected to propel growth of the global ranitidine market. Several government and commercial research institutions are actively involved in research and development studies to improve the efficacy of ranitidine and explore its potential to expand the breadth of the ranitidine market in the future.
Several clinical studies are presently being conducted to determine and evaluate the efficacy of ranitidine with other proton pump inhibitors like esomeprazole and rabeprazole in reducing gastric acid in the stomach. The efficacy of ranitidine is likely to increase as a consequence of these trials, and improved treatment regimens for excessive stomach acid production should be available in the near future. A Phase III clinical trial comparing the effectiveness of rabeprazole extended release (ER) 50 mg vs ranitidine 150 mg in the treatment of erosive gastroesophageal reflux disease (eGERD) began in November 2015.
The global ranitidine market is projected to grow due to the rising number of cases of various gastric ulcers and digestive diseases. Due to an increase in the occurrence of gastroesophageal reflux disease (GERD), gastric and abdomen ulcers, esophagitis, heartburn, and other digestive diseases caused by an eating disorder and altering eating habits, demand for ranitidine-based medications is expected to rise in the near future. As per Florida Hospital data from 2018, approximately 60 million individuals in the United States suffer with acid reflux symptoms on a monthly basis. According to the report, around 25 million from the 60 million individuals suffer with acid reflux symptoms on a daily basis. According to the same source, around 20% of those who suffer from acid reflux will acquire gastroesophageal reflux disease (GERD) in the near future.
One of the most common symptoms of gastroesophageal reflux disease is heartburn with or without regurgitation (GERD). According to the World Gastroenterology Organization (WGO), GERD prevalence is rapidly growing across the world, with occurrence ranging from 2.5 percent to 6.6 percent in Eastern Asia and somewhat higher in North America (13.8 percent to 25.8%).
The cause of the increased incidence of GERD is unknown; however, it appears to be linked to rising obesity rates and a variety of dietary variables. Excessive belly fat puts additional pressure on the stomach in obese people, producing acid reflux and heartburn. As the number of obese people throughout the world rises, so will the number of GERD cases, which is estimated to augment growth of the global ranitidine market. As per the World Health Organization (WHO), over 1.9 billion individuals aged 18 and over were overweight in 2016, with over 650 million of them being overweight. GERD is also linked to an increased risk of Barrett’s esophagus, a premalignant disease that destroys the esophageal tube.
Restraints
The global ranitidine market’s expansion will be limited by the FDA’s strict regulatory standards in the manufacture of finished medicines. Due to its unusual form and coatings, the Ministry of Food and Drug Safety of South Korea prohibited the importation of 150 mg Zantac (ranitidine) supplied by GlaxoSmithKline (GSK) Korea for four months (March to June 2018). GSK violated the Pharmaceutical Affairs Act by altering the authorized form of Zantac, according to a complaint from South Korea’s Ministry of Food and Drug Safety. Zantac is intended to be white and spherical with thin film coverings on both sides, however, GSK supplied Zantac with a thick coated film that was slightly damaged around part of the pills. Color, flavor, and packaging changes may compromise medicine safety and efficacy, which has a direct impact on product quality.
Moreover, one of the most difficult aspects of establishing the prevalence of GERD is identifying individuals who have the illness. Patients who are experiencing GERD symptoms often do not seek medical help until the symptoms become severe. During the forecast period, this is projected to hinder the growth of the global ranitidine market.
Main points in Ranitidine Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Ranitidine Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Ranitidine Industry Impact
Chapter 2 Global Ranitidine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Ranitidine (Volume and Value) by Type
2.3 Global Ranitidine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Ranitidine Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Ranitidine Market Analysis
Chapter 6 East Asia Ranitidine Market Analysis
Chapter 7 Europe Ranitidine Market Analysis
Chapter 8 South Asia Ranitidine Market Analysis
Chapter 9 Southeast Asia Ranitidine Market Analysis
Chapter 10 Middle East Ranitidine Market Analysis
Chapter 11 Africa Ranitidine Market Analysis
Chapter 12 Oceania Ranitidine Market Analysis
Chapter 13 South America Ranitidine Market Analysis
Chapter 14 Company Profiles and Key Figures in Ranitidine Business
Chapter 15 Global Ranitidine Market Forecast (2021-2027)
Chapter 16 Conclusions
View Press Release For More Information
Related Reports:
Plant-based Vaccines Market, by Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, and Others), by Source (Tobacco Plant, Maize, Potato, and Others), by Application (Influenza, Covid-19, Zika Virus, Ebola Virus, Poultry Disease, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market, by Drug Class (Glycopeptides and Lipoglycopeptides, Oxazolidinones, Lipopeptides, Cephalosporin, Tetracycline, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
